DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Saag KG, Wagman RB, Geusens P. et al.
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a
multicentre, randomised, double-blind, active-controlled, double-dummy,
non-inferiority study.
Lancet Diabetes Endocrinol 2018;
6 (06) 445-454
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.